Literature DB >> 24781414

Reply: Regulatory T cells-an important target for cancer immunotherapy.

Charles G Drake1, Evan J Lipson1, Julie R Brahmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24781414      PMCID： PMC4732695          DOI： 10.1038/nrclinonc.2013.208-c2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

Review 1.  Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer.

Authors:  Charles G Drake; Evan J Lipson; Julie R Brahmer
Journal:  Nat Rev Clin Oncol       Date:  2013-11-19       Impact factor: 66.675

2.  Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.

Authors:  Daisuke Sugiyama; Hiroyoshi Nishikawa; Yuka Maeda; Megumi Nishioka; Atsushi Tanemura; Ichiro Katayama; Sachiko Ezoe; Yuzuru Kanakura; Eiichi Sato; Yasuo Fukumori; Julia Karbach; Elke Jäger; Shimon Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

3.  Regulatory T cells-an important target for cancer immunotherapy.

Authors:  Jae Il Shin; Sang-Jun Ha
Journal:  Nat Rev Clin Oncol       Date:  2014-04-29       Impact factor: 66.675

Review 4.  LAG-3 in Cancer Immunotherapy.

Authors:  Monica V Goldberg; Charles G Drake
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

5.  Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.

Authors:  Mark J Selby; John J Engelhardt; Michael Quigley; Karla A Henning; Timothy Chen; Mohan Srinivasan; Alan J Korman
Journal:  Cancer Immunol Res       Date:  2013-04-07       Impact factor: 11.151

6.  PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.

Authors:  Wenshi Wang; Roy Lau; Daohai Yu; Weiwei Zhu; Alan Korman; Jeffrey Weber
Journal:  Int Immunol       Date:  2009-08-03       Impact factor: 4.823

7.  Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.

Authors:  Tyler R Simpson; Fubin Li; Welby Montalvo-Ortiz; Manuel A Sepulveda; Katharina Bergerhoff; Frederick Arce; Claire Roddie; Jake Y Henry; Hideo Yagita; Jedd D Wolchok; Karl S Peggs; Jeffrey V Ravetch; James P Allison; Sergio A Quezada
Journal:  J Exp Med       Date:  2013-07-29       Impact factor: 14.307
  7 in total
  2 in total

1.  Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models.

Authors:  P F Forde; L J Hall; M de Kruijf; M G Bourke; T Doddy; M Sadadcharam; D M Soden
Journal:  Gene Ther       Date:  2014-11-06       Impact factor: 5.250

2.  Pentoxifylline Inhibits WNT Signalling in β-Cateninhigh Patient-Derived Melanoma Cell Populations.

Authors:  Beata Talar; Anna Gajos-Michniewicz; Marcin Talar; Salem Chouaib; Malgorzata Czyz
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.